Locus Cell Business Summary

Locus Cell Co., Ltd. (6891.TWO) operates as a specialized Contract Development and Manufacturing Organization (CDMO) focused on the rapidly expanding cell and gene therapy (CGT) sector. The company generates revenue through fee-for-service contracts and milestone-based licensing for process development, analytical validation, and clinical-to-commercial GMP manufacturing. Its primary business segments include tissue engineering (adipose-derived stem cells, 3D-printed cell products) and regenerative medicine (CAR-T, CAR-NK, iPSC, and MSC therapies). Locus Cell differentiates itself through its "digital-native smart cell factory" in Zhubei, Taiwan, developed in partnership with the Hitachi Group to integrate AIoT and automated PIC/S GMP systems. In the global CDMO landscape, it competes with major players such as WuXi Advanced Therapies (WuXi AppTec), Oxford BioMedica, and Catalent (MaSTherCell), positioning itself as a high-tech, cost-competitive bridge for international biotech firms seeking to scale advanced therapies in the Asia-Pacific region. The leadership team is anchored by CEO Sean Chang (Yu Hsiang Chang), a prominent hematologist with over 20 years of clinical experience and a PhD in CAR-T research from the laboratory of Dr. Dario Campana, the inventor of the first CAR-T construct. Chang holds international patents for NK cell-based CAR therapies and previously led cell manufacturing at National Taiwan University. Chairman Jiunn-Rong Chiou brings significant institutional pedigree, having served as the Superintendent of National Cheng Kung University Hospital and as a director for the Industrial Technology Research Institute (ITRI). The company is backed by strategic investors and joint venture partners including MetaTech (AP) Inc., Taiwan Hitachi Asia Pacific, and Zig Sheng Industrial, providing a robust foundation of industrial manufacturing expertise and capital for its international expansion, recently evidenced by its Phase III manufacturing partnership with Australia-based Cambium Bio.